Souhaitez-vous accéder aux communiqués récents ?

All amounts in U.S. dollars unless otherwise stated TORONTO, May 11, 2026 (GLOBE NEWSWIRE) -- Onex Partners today announced the sale of Emerald Holding Inc. (NYSE:EEX) (“Emerald” or the Company”),...

Company has sold five of its properties in 2026 and entered into purchase and sale agreements covering four of its remaining five properties  Continues to target completing all remaining sales by...

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that Apollo-managed funds (the “Apollo Funds”) have entered into separate definitive agreements to acquire Emerald...

Dubai, UAE, May 09, 2026 (GLOBE NEWSWIRE) -- Pepeto keeps moving closer to its tier 1 exchange listings, with presale rounds closing at a speed that shows exactly how the largest wallets in the...

NVIDIA Names Suzanne Nora Johnson to Board of Directors

SOUTH SAN FRANCISCO, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the closing of an underwritten public offering of 11,338,028 shares of its...

Transaction in Own Shares    07 May, 2026 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 07 May, 2026 it purchased the following number of Shares for cancellation. ...

AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI) (“Mobia Medical”), a commercial-stage medical device company redefining stroke recovery for survivors living with...

Myriad Genetics will participate in The BofA Securities 2026 Health Care Conference and Goldman Sachs 47th Annual Global Healthcare Conference.

FDA approved AVLAYAH™ (tividenofusp alfa-eknm) for treatment of Hunter syndrome (MPS II) and as first medicine to leverage transferrin receptor to cross blood-brain barrierAVLAYAH launched in U.S....